Gujarat Kidney And Super Speciality Limited (NSE:GKSL)

India · Delayed Price · Currency is INR

179.46

-4.43 (-2.41%)

At close: Oct 22, 2026

Market Cap	14.15B
Revenue (ttm)	1.01B +118.9%
Net Income	158.34M +38.4%
EPS	2.34 +10.2%
Shares Out	78.84M
PE Ratio	76.63
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	267,305
Open	183.86
Previous Close	183.89
Day's Range	178.03 - 183.86
52-Week Range	98.36 - 209.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About NSE:GKSL

Gujarat Kidney and Super Speciality Limited operates multi-specialty and super-specialty hospitals in India. It provides treatment for Oncology, Neurology, Gastroenterology, Urology, Nephrology, and Physiotherapy. It also offers Renal Surgery, Vascular Surgery, Gynecology and obstetrics, Robotic Surgery, Bariatric Surgery, Laparoscopic Surgery, Endocrine Surgery, Neurosurgery, and Joint Replacement services. Its facilities include intensive care unit, rooms, patient counselling, operation theatres, and dialysis center. Gujarat Kidney And Super ... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 2014

Employees 194

Stock Exchange National Stock Exchange of India

Ticker Symbol GKSL

Full Company Profile

Financial Performance

In fiscal year 2026, NSE:GKSL's revenue was 820.13 million, an increase of 103.80% compared to the previous year's 402.42 million. Earnings were 154.97 million, an increase of 64.63%.

Financial Statements